3-(3-chloro-5-methylphenyl)-6-(3-fluoro-2-hydroxyphenyl)-N,7-dimethyl-N-(pyrrolidin-2-ylmethyl)-3,4-dihydroquinazoline-4-carboxamide

ID: ALA4783565

Chembl Id: CHEMBL4783565

PubChem CID: 162666722

Max Phase: Preclinical

Molecular Formula: C29H30ClFN4O2

Molecular Weight: 521.04

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(Cl)cc(N2C=Nc3cc(C)c(-c4cccc(F)c4O)cc3C2C(=O)N(C)CC2CCCN2)c1

Standard InChI:  InChI=1S/C29H30ClFN4O2/c1-17-10-19(30)13-21(11-17)35-16-33-26-12-18(2)23(22-7-4-8-25(31)28(22)36)14-24(26)27(35)29(37)34(3)15-20-6-5-9-32-20/h4,7-8,10-14,16,20,27,32,36H,5-6,9,15H2,1-3H3

Standard InChI Key:  FGVUWBKWBAZBPK-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4783565

    ---

Associated Targets(Human)

SSTR2 Tclin Somatostatin receptor 2 (1526 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Sstr2 Somatostatin receptor 2 (164 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 521.04Molecular Weight (Monoisotopic): 520.2041AlogP: 5.90#Rotatable Bonds: 5
Polar Surface Area: 68.17Molecular Species: BASEHBA: 5HBD: 2
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 8.23CX Basic pKa: 10.56CX LogP: 4.59CX LogD: 3.76
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.44Np Likeness Score: -0.35

References

1. Zhao J,Wang S,Han S,Kim SH,Kusnetzow AK,Nguyen J,Rico-Bautista E,Tan H,Betz SF,Scott Struthers R,Zhu Y.  (2020)  Discovery of nonpeptide 3,4-dihydroquinazoline-4-carboxamides as potent and selective sst2 agonists.,  30  (17.0): [PMID:32738999] [10.1016/j.bmcl.2020.127391]
2. Zhao J,Wang S,Han S,Kim SH,Kusnetzow AK,Nguyen J,Rico-Bautista E,Tan H,Betz SF,Scott Struthers R,Zhu Y.  (2020)  Discovery of nonpeptide 3,4-dihydroquinazoline-4-carboxamides as potent and selective sst2 agonists.,  30  (17.0): [PMID:32738999] [10.1016/j.bmcl.2020.127391]

Source